GO:0016223 beta-alanine:pyruvate transaminase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0016223 describes the molecular function beta-alanine:pyruvate transaminase activity, which catalyzes the reversible transfer of an amino group between L-alanine and 3-oxopropanoate to produce beta-alanine and pyruvate.
• The enzyme belongs to the pyridoxal 5'-phosphate (PLP)-dependent aminotransferase family and is also known as omega-amino acid--pyruvate aminotransferase.
• In bacteria such as Burkholderia cepacia, beta-alanine:pyruvate transaminase participates in pyrimidine base catabolism, linking uracil and thymine breakdown to central metabolism.
• In mammals, beta-alanine aminotransferase activity is influenced by dietary protein levels, indicating nutritional regulation of this metabolic step.
• The enzyme is a promising biocatalyst for kinetic resolution of beta-amino acids and amines, with applications in pharmaceutical and fine-chemical synthesis.
• Studying GO:0016223 requires integrating enzyme assays, CRISPR-based gene editing, and metabolic profiling to connect genotype to flux.
Description
GO:0016223, beta-alanine:pyruvate transaminase activity, is a molecular function defined by the reversible transamination reaction L-alanine + 3-oxopropanoate = beta-alanine + pyruvate. This activity sits at the intersection of amino acid metabolism and pyrimidine catabolism, and it is conserved from bacteria to mammals. In Burkholderia cepacia, the enzyme is required for pyrimidine base catabolism, allowing the organism to use uracil and thymine as carbon and nitrogen sources. In rats, beta-alanine aminotransferase expression and activity respond to dietary protein levels, suggesting a role in nitrogen handling and beta-alanine homeostasis. For researchers, GO:0016223 provides a defined enzymatic activity to interrogate metabolic rewiring, enzyme evolution, and biocatalytic potential. The term is also relevant to drug discovery because beta-alanine analogs and beta-amino acids are important chiral building blocks. Understanding this activity at the molecular level enables precise CRISPR-based models to test its contribution to cellular metabolism and disease.
beta-alanine:pyruvate transaminase activity At A Glance
| GO ID | GO:0016223 |
|---|---|
| GO term | beta-alanine:pyruvate transaminase activity |
| Ontology | molecular_function |
| Synonym | beta-alanine-alpha-alanine transaminase activity; beta-alanine--pyruvate aminotransferase activity; beta-alanine-pyruvate aminotransferase activity; L-alanine:3-oxopropanoate aminotransferase activity; omega-amino acid--pyruvate aminotransferase activity |
| Major function | Reversible transamination between L-alanine and 3-oxopropanoate to yield beta-alanine and pyruvate |
| Cofactor | Pyridoxal 5'-phosphate (PLP) |
| Reaction | L-alanine + 3-oxopropanoate = beta-alanine + pyruvate |
| Organisms | Bacteria (e.g., Burkholderia cepacia), mammals (e.g., rat), and other species |
| Related process | Pyrimidine base catabolism; beta-alanine metabolism |
What Is GO:0016223?
Beta-alanine:pyruvate transaminase activity (GO:0016223) is the catalysis of the reaction L-alanine + 3-oxopropanoate = beta-alanine + pyruvate. In this reversible reaction, the amino group from L-alanine is transferred to 3-oxopropanoate (malonate semialdehyde) to form beta-alanine, while L-alanine is converted to pyruvate. The enzyme uses pyridoxal 5'-phosphate as a cofactor and belongs to the class of omega-amino acid--pyruvate aminotransferases.
Why Is beta-alanine:pyruvate transaminase activity Important in Cell Biology?
GO:0016223 is important because it connects amino acid metabolism, pyrimidine catabolism, and the production of beta-alanine, a precursor of carnosine and a signaling molecule. In bacteria, this activity is essential for using pyrimidine bases as nutrients. In mammals, dietary protein levels modulate beta-alanine aminotransferase, linking nutrition to metabolic flux. The enzyme also serves as a biocatalyst for producing chiral beta-amino acids, which are valuable in drug development. Thus, GO:0016223 is a focal point for metabolic engineering, enzymology, and disease research.
• Enables pyrimidine base catabolism in bacteria such as Burkholderia cepacia.
• Contributes to beta-alanine homeostasis, which affects carnosine synthesis and pH buffering in muscle.
• Is regulated by dietary protein intake in rats, linking nutrition to enzyme expression.
• Provides a biocatalytic route for kinetic resolution of beta-amino acids and amines.
• Represents a target for metabolic engineering of nitrogen and carbon flux.
• Serves as a model for PLP-dependent transaminase mechanism and inhibition.
• May influence drug metabolism and detoxification pathways involving beta-alanine analogs.
• Offers a selectable metabolic marker for CRISPR screens in bacteria and mammalian cells.
• Connects to cancer metabolism through altered amino acid transamination.
• Supports the development of chiral building blocks for pharmaceuticals.
Molecular Mechanism of beta-alanine:pyruvate transaminase activity
Substrate Recognition and Binding
In simple terms: The enzyme grabs L-alanine and 3-oxopropanoate and holds them in place.
The active site of beta-alanine:pyruvate transaminase binds L-alanine and 3-oxopropanoate with stereospecificity. The enzyme belongs to the omega-amino acid--pyruvate transaminase family, which recognizes a broad range of omega-amino acids and pyruvate as amino acceptors. Substrate binding is mediated by conserved residues that position the amino group of L-alanine near the PLP cofactor.
PLP-Dependent Transamination
In simple terms: A vitamin B6 derivative helps move the amino group from one molecule to another.
The catalytic mechanism relies on pyridoxal 5'-phosphate (PLP), which forms a Schiff base with the amino group of L-alanine. This intermediate facilitates the transfer of the amino group to 3-oxopropanoate, yielding beta-alanine and pyruvate. The reaction is reversible, and the equilibrium can be shifted by substrate availability.
Role in Pyrimidine Catabolism
In simple terms: The enzyme helps break down uracil and thymine into usable pieces.
In Burkholderia cepacia, beta-alanine:pyruvate transaminase is part of the pyrimidine base catabolic pathway. It converts beta-alanine, a product of uracil and thymine degradation, into pyruvate and 3-oxopropanoate, feeding into central metabolism. This activity allows the bacterium to use pyrimidines as carbon and nitrogen sources.
Nutritional and Hormonal Regulation
In simple terms: What you eat can change how much of this enzyme you make.
In rats, dietary protein levels influence beta-alanine aminotransferase expression and activity. Higher protein intake correlates with increased enzyme activity, suggesting that this transaminase participates in nitrogen disposal and amino acid homeostasis. This regulation may involve hormonal signals and substrate availability.
Biocatalytic Applications
In simple terms: The enzyme can be used in the lab to make pure beta-amino acids.
Omega-amino acid:pyruvate transaminase from Alcaligenes denitrificans Y2k-2 efficiently catalyzes the kinetic resolution of beta-amino acids and amines, making it a valuable biocatalyst for producing enantiopure compounds. This application highlights the industrial relevance of GO:0016223.
Key Genes Involved in GO:0016223 beta-alanine:pyruvate transaminase activity
The following genes and proteins are associated with beta-alanine:pyruvate transaminase activity or related transamination pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Bcbeta-AlaAT | Beta-alanine:pyruvate transaminase in Burkholderia cepacia | Pyrimidine catabolism model |
| omega-TA | Omega-amino acid:pyruvate transaminase from Alcaligenes denitrificans | Biocatalysis and kinetic resolution |
| Rat beta-AlaAT | Beta-alanine aminotransferase in rat liver | Dietary regulation studies |
| D-AlaAT | D-alanine aminotransferase in Staphylococcus aureus | Resistance to beta-chloro-D-alanine |
| D-AAT | Bacterial D-amino acid transaminase | Inactivation by beta-chloro-D-alanine |
| Glutamine transaminase K | Broad-specificity aminotransferase | Cysteine S-conjugate beta-lyase activity |
| GPT | Alanine aminotransferase | Central nitrogen metabolism |
| GOT1 | Aspartate aminotransferase | Amino acid metabolism |
| AGXT | Alanine:glyoxylate aminotransferase | Peroxisomal metabolism |
| KYAT1 | Kynurenine aminotransferase | Tryptophan metabolism |
| GAD1 | Glutamate decarboxylase | GABA synthesis |
| ALDH | Aldehyde dehydrogenase | 3-oxopropanoate metabolism |
| PANDER | Pancreatic-derived factor | Beta-cell function |
| SLC36A1 | Proton-coupled amino acid transporter | Beta-alanine transport |
| CNDP2 | Cytosolic nonspecific dipeptidase | Beta-alanine generation |
| CARNS1 | Carnosine synthase | Beta-alanine utilization |
| ABAT | 4-aminobutyrate aminotransferase | GABA catabolism |
How Is beta-alanine:pyruvate transaminase activity Regulated?
Beta-alanine:pyruvate transaminase activity is regulated at multiple levels. In bacteria, expression is induced by the availability of pyrimidine bases as substrates. In mammals, dietary protein levels modulate enzyme expression and activity, likely through hormonal and nutritional signals. The enzyme's activity can also be regulated by PLP availability and by feedback inhibition from products such as pyruvate and beta-alanine. Additionally, post-translational modifications and protein stability may influence steady-state activity, though specific mechanisms require further study.
beta-alanine:pyruvate transaminase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Bcbeta-AlaAT | Pyrimidine catabolism in Burkholderia cepacia | Knockout in B. cepacia |
| D-AlaAT | Antibiotic resistance in S. aureus | Point mutation S180F |
| Rat beta-AlaAT | Dietary protein response | Overexpression in rat liver |
| omega-TA | Biocatalysis for chiral amines | Directed evolution |
| GPT | Liver metabolic disorders | Knockout mouse |
Cancer Metabolism
Altered amino acid transamination is a hallmark of cancer metabolism. Metabolic dysregulation in hepatocellular carcinoma involves changes in transaminase activities that support tumor growth and survival. Beta-alanine:pyruvate transaminase may contribute to these metabolic adaptations by supplying pyruvate and beta-alanine for biosynthetic pathways.
Antibiotic Resistance
D-alanine aminotransferase, a related PLP-dependent enzyme, is targeted by beta-chloro-D-alanine in Staphylococcus aureus. A S180F substitution confers resistance, highlighting how mutations in transaminases can lead to antibiotic resistance. Understanding similar resistance mechanisms for beta-alanine:pyruvate transaminase is important for drug design.
Metabolic Disorders
Beta-alanine is a precursor of carnosine, which buffers muscle pH. Dysregulation of beta-alanine metabolism has been linked to metabolic stress and muscle fatigue. Dietary protein levels influence beta-alanine aminotransferase activity in rats, suggesting a role in nitrogen balance and metabolic health.
From beta-alanine:pyruvate transaminase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of beta-alanine:pyruvate transaminase impair pyrimidine catabolism? | Knockout in Burkholderia cepacia |
| How does dietary protein affect enzyme activity? | Overexpression in rat liver |
| Can point mutations alter substrate specificity? | Point mutation in omega-TA |
| Does the enzyme contribute to antibiotic resistance? | Knock-in of S180F in D-AlaAT |
| What is the role of PLP binding? | Tagged knock-in for affinity purification |
| Can the enzyme be used for chiral synthesis? | Overexpression in E. coli |
How to Study the beta-alanine:pyruvate transaminase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Enzymatic assay | Transaminase activity | Kinetic characterization |
| CRISPR knockout screen | Gene essentiality | Metabolic pathway discovery |
| Metabolomics | Metabolite levels | Flux analysis |
| Isotope tracing | Pathway flux | In vivo metabolism |
| X-ray crystallography | Protein structure | Active site mapping |
| Directed evolution | Enzyme variants | Biocatalyst optimization |
| Western blot | Protein expression | Regulation studies |
Enzymatic Assays
Direct measurement of beta-alanine:pyruvate transaminase activity uses coupled assays that monitor pyruvate formation or beta-alanine production. These assays are essential for kinetic characterization and inhibitor screening.
CRISPR-Cas9 Knockout Screens
Genome-wide CRISPR knockout screens can identify genes required for beta-alanine utilization or pyrimidine catabolism. Such screens link GO:0016223 to cellular fitness and metabolic networks.
Metabolomics and Flux Analysis
LC-MS-based metabolomics quantifies beta-alanine, pyruvate, and 3-oxopropanoate levels. Isotope tracing can measure flux through the transamination reaction in cells and tissues.
Structural Biology
X-ray crystallography and cryo-EM reveal the active site architecture and PLP binding mode of omega-amino acid:pyruvate transaminases, guiding rational engineering.
How CRISPR Can Be Used to Study GO:0016223 beta-alanine:pyruvate transaminase activity
Knockout
CRISPR-Cas9 knockout of beta-alanine:pyruvate transaminase genes in bacteria or mammalian cells can reveal their role in pyrimidine catabolism and beta-alanine homeostasis. Knockout models are useful for testing metabolic dependencies.
Point Mutation
Introducing point mutations such as S180F in related transaminases can confer resistance to inhibitors like beta-chloro-D-alanine. CRISPR-based point mutation models help dissect catalytic residues and drug resistance mechanisms.
Knock-in
Knock-in of tagged versions of the enzyme (e.g., FLAG or GFP) enables affinity purification and live-cell imaging. This approach is valuable for studying subcellular localization and protein interactions.
Overexpression
CRISPR activation or plasmid-based overexpression of omega-amino acid:pyruvate transaminase boosts enzyme levels for biocatalysis and metabolic flux studies. Overexpression in E. coli is commonly used for enzyme production.
How EDITGENE Supports beta-alanine:pyruvate transaminase activity Research
Researchers studying beta-alanine:pyruvate transaminase activity-related genes often need to determine whether a candidate gene is causally involved in metabolic pathways, disease phenotypes, or biocatalytic potential. EDITGENE provides end-to-end CRISPR solutions to generate precisely engineered cell models, enabling rigorous functional validation of GO:0016223-associated genes.
Contact EDITGENE today to design your custom CRISPR model for beta-alanine:pyruvate transaminase activity research.
Frequently Asked Questions About beta-alanine:pyruvate transaminase activity
What is beta-alanine:pyruvate transaminase activity?
It is a molecular function (GO:0016223) that catalyzes the reversible transfer of an amino group from L-alanine to 3-oxopropanoate, producing beta-alanine and pyruvate.
What genes are involved in beta-alanine:pyruvate transaminase activity?
Genes encoding omega-amino acid:pyruvate transaminases, such as those from Alcaligenes denitrificans and Burkholderia cepacia, as well as related D-amino acid transaminases.
What is the reaction catalyzed by GO:0016223?
L-alanine + 3-oxopropanoate = beta-alanine + pyruvate.
What cofactor does beta-alanine:pyruvate transaminase use?
It uses pyridoxal 5'-phosphate (PLP) as a cofactor.
How is beta-alanine:pyruvate transaminase regulated?
In bacteria, it is induced by pyrimidine bases; in mammals, dietary protein levels influence its expression and activity.
What diseases are associated with beta-alanine:pyruvate transaminase?
Altered transamination is linked to cancer metabolism and antibiotic resistance in related enzymes.
Can beta-alanine:pyruvate transaminase be used in biocatalysis?
Yes, omega-amino acid:pyruvate transaminases are used for kinetic resolution of beta-amino acids and amines.
What model systems are used to study GO:0016223?
Bacterial knockout models, rat dietary studies, and CRISPR-engineered mammalian cells.
How can CRISPR help study beta-alanine:pyruvate transaminase activity?
CRISPR knockout, point mutation, knock-in, and overexpression models enable precise functional dissection of the enzyme in cells.
What methods measure beta-alanine:pyruvate transaminase activity?
Enzymatic assays, metabolomics, isotope tracing, and structural biology.
Conclusion
GO:0016223, beta-alanine:pyruvate transaminase activity, is a fundamental molecular function that bridges amino acid and pyrimidine metabolism. Its roles in bacterial catabolism, mammalian nutrition, and biocatalysis make it a versatile target for research. By combining CRISPR-based gene editing with metabolic and structural approaches, scientists can uncover new insights into this enzyme's regulation and therapeutic potential.
References
- 1. Du D et al.. 2022. Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma.. Acta Pharm Sin B 12(2):558-580 PMID: 35256934
- 3. West TP. 2000. Role of cytosine deaminase and beta-alanine-pyruvate transaminase in pyrimidine base catabolism by Burkholderia cepacia.. Antonie Van Leeuwenhoek 77(1):1-5 PMID: 10696871
- 4. Roy R et al.. 2025. A S(180)F substitution in D-alanine aminotransferase confers resistance to β-chloro-D-alanine in Staphylococcus aureus.. J Biol Chem 301(12):110931 PMID: 41232672
- 6. Soper TS et al.. 1977. Inactivation of bacterial D-amino acid transaminase by beta-chloro-D-alanine.. J Biol Chem 252(10):3170-5 PMID: 863877
- 7. Ito S et al.. 2001. Influence of dietary protein levels on beta-alanine aminotransferase expression and activity in rats.. J Nutr Sci Vitaminol (Tokyo) 47(4):275-82 PMID: 11767207
- 8. Yun H et al.. 2004. omega-Amino acid:pyruvate transaminase from Alcaligenes denitrificans Y2k-2: a new catalyst for kinetic resolution of beta-amino acids and amines.. Appl Environ Microbiol 70(4):2529-34 PMID: 15066855
